ONMD Stock Risk & Deep Value Analysis

Onemednet Corp

Healthcare โ€ข Health Information Services

DVR Score

1.0

out of 10

Distressed

The Bottom Line on ONMD

We analyzed Onemednet Corp using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran ONMD through our deep value framework โ€” analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Mar 30, 2026โ€ขRun Fresh Analysis โ†’โ€ข

Get notified when ONMD moves

Same alert types as Telegram โ€” presets or custom thresholds in your ๐Ÿ”” feed.

๐Ÿ“ˆONMD Performance Overview3yr weekly

๐Ÿ“Š

Unlock ONMD Performance Chart

See 3 years of price history, quarterly revenue trends, and DVR score changes

Weekly adjusted close ยท Quarterly revenue & EPS ยท DVR score history

ONMD Stock Risk Analysis

Overall Risk

Aggressive

Financial Risk

High

Market Risk

Medium

About Onemednet Corp (ONMD)

Sector

Healthcare

Industry

Health Information Services

Market Cap Category

small

ONMD Deep Value Analysis

Onemednet Corp operates in the attractive real-world data (RWD) and imaging RWD (iRWDโ„ข) market, which is the primary driver for any speculative potential. However, as of 2026-03-30, no material positive changes have been observed since the prior analysis on 2026-03-09. The company remains severely constrained by profound financial instability, critically high cash burn, and minimal to negative revenue growth, leading to an unsustainable financial trajectory. The persistent lack of a clear, executable path to profitability and ongoing severe dilution risks continue to overshadow its strategic market positioning. The probability of achieving 10x growth is exceptionally low given these critical and unaddressed financial red flags, maintaining its highly precarious and speculative investment status. The score remains consistent with previous analyses due to the absence of fundamental shifts.

ONMD Research Sources

Research sources

No external source links for this analysis yet. Run a fresh analysis to capture SEC filings and financial news articles we used.

For educational context only. Not financial advice.

ONMD Red Flags & Warning Signs

  • โš 

    Failure to secure additional funding leading to liquidity crisis

  • โš 

    Accelerated share dilution without corresponding business growth

  • โš 

    Potential delisting from exchange due to low share price or non-compliance

Unlock ONMD Red Flags & Risk Warnings

Premium members see every risk event we found.

๐Ÿ“ˆ

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

๐Ÿ”ฅ New Member Exclusive

Unlock everything for $47/yr

$79/yrSave 41%

  • โœ“ Catalysts, bull case, moat & red flags
  • โœ“ Unlimited stock analyses + alerts
  • โœ“ Full database, search & portfolio (50 stocks)
Get Premium โ€” $47/yr

7-day money back ยท Cancel anytime

ONMD Competitive Moat Analysis

Moat Rating

None

Moat Trend

Eroding

Moat Sources

1 Identified

Intangible Assets/IP (if iRWDโ„ข technology is genuinely unique and defensible)

The potential intellectual property and niche focus may offer a theoretical moat, but it is not durable without significant capital investment, successful execution, and a stable financial footing. Current financial distress actively erodes any potential moat.

ONMD Competitive Moat Analysis

Premium unlocks moat rating, sources & durability.

ONMD Catalysts & Growth Drivers

Near-Term (0-6 months)

  • โ€ขAnnouncement of successful, non-dilutive financing round (highly unlikely currently)
  • โ€ขMaterial reduction in quarterly cash burn

Medium-Term (6-18 months)

  • โ€ขSignificant commercial contract wins that show accelerated revenue growth
  • โ€ขStrategic partnership with a major pharmaceutical or healthcare entity

Long-Term (18+ months)

  • โ€ขAchieving sustainable positive free cash flow and profitability
  • โ€ขDemonstrating clear market leadership in a niche iRWD segment

Catalysts & Growth Drivers

Sign up free to see growth catalysts

ONMD Bull Case: What Could Go Right

  • โœ“

    Clear and sustainable reduction in quarterly cash burn

  • โœ“

    Announcement of a substantial, non-dilutive (or minimally dilutive) funding round

  • โœ“

    Significant acceleration in revenue growth (e.g., consecutive quarters of 50%+ sequential growth)

Bull Case Analysis

Sign up free to see the bull case

๐Ÿ“Š Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

FAQ

What is the DVR Score for Onemednet Corp (ONMD)?

As of March 30, 2026, Onemednet Corp has a DVR Score of 1.0 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What ticker symbol does Onemednet Corp use?

ONMD is the ticker symbol for Onemednet Corp. The company trades on the NCM.

What is the risk level for ONMD stock?

Our analysis rates Onemednet Corp's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

How often is the ONMD DVR analysis updated?

Our AI-powered analysis of Onemednet Corp is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on March 30, 2026.

Important Disclaimer โ€“ Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.